1.
Kareem Ali Maher, Reda Biomy Bastawesy, Mahmoud Mohammed AbdouYossef, Mariam Salah Zaghlol, Wael Anwer Haseeb. Cardiovascular Risk Assessment after Sofosbuvir and Daclatasvir Regimen for Chronic Hepatitis C Virus Infection. J Pak Med Assoc [Internet]. 2023 May 25 [cited 2026 May 24];73(4):S136-S141. Available from: https://jpma.org.pk/index.php/public_html/article/view/9838